Generate Biomedicines Files for Proposed Nasdaq IPO
Generate Biomedicines has submitted paperwork for a proposed initial public offering on the Nasdaq. The clinical-stage firm says its integrated Generate Platform combines computational methods with scalable biohardware to design and advance protein therapeutics, and has progressed three computationally engineered proteins into human testing, includ…